General Thyroid Cancer

Pass it On: It’s National Thyroid Awareness Month (September 8, 2016)

The thyroid gland is a butterfly-shaped organ that is below the Adam’s apple in the front part of the neck. It produces, stores, and releases hormones that regulate vital body functions. Thyroid cancer... Continue Reading

Complications Decrease with Surgeon Experience in Thyroidectomy (April 6, 2016)

Among patients undergoing the surgical removal of their thyroid, complications associated with the procedure are drastically reduced if surgeons perform a larger number of the surgeries per year. These... Continue Reading

National Thyroid Cancer Awareness Month on CancerConnect (September 8, 2015)

  As the month of September brings thyroid cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment... Continue Reading

National Thyroid Cancer Awareness Month on CancerConnect (September 10, 2014)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of educational programs for national thyroid cancer awareness month. As the month of September brings thyroid cancer... Continue Reading

Nexavar Approved for Metastatic Differentiated Thyroid Cancer (December 9, 2013)

The U.S. Food and Drug Administration (FDA) has approved Nexavar® (sorafenib) for the treatment of metastatic differentiated thyroid cancer. Differentiated thyroid cancer is the most common type of thyroid... Continue Reading

Mutations Linked to Drug Response in Medullary Thyroid Cancer (November 15, 2013)

Metastatic medullary thyroid cancers with certain genetic mutations respond better to treatment with Cometriq™ (cabozantinib) than tumors without those mutations, according to the results of a study... Continue Reading

TSH Suppression after Thyroidectomy May Not Be Beneficial (November 4, 2013)

Suppression of thyroid-stimulating hormone (TSH) after thyroidectomy for low-risk cancer does not appear to reduce the risk of cancer recurrence and may even increase the risk of osteoporosis in women,... Continue Reading

Thyroid Ultrasound May Cut Biopsy Rate (September 13, 2013)

Thyroid ultrasound may help identify certain characteristics of thyroid nodules that can predict the likelihood of cancer—and subsequently help determine whether biopsy is necessary, according to the... Continue Reading

BRAF V600E mutation Increases Death Risk in Papillary Thyroid Cancer (June 5, 2013)

The presence of the BRAF V600E mutation is significantly associated with increased cancer-related death among patients with papillary thyroid cancer, according to the results of a study published in the... Continue Reading

Selumetinib May Reverse Radioiodine Resistance in Advance Thyroid Cancer (March 28, 2013)

The experimental drug selumetinib (AZD6244) may help some patients with advanced thyroid cancer overcome resistance to radioiodine, which is the most effective treatment for the disease, according to the... Continue Reading

Gene Expression Test Identifies Low-Risk Thyroid Nodules (June 28, 2012)

A new test measures gene expression in thyroid nodules with inconclusive biopsy results and helps identify low-risk nodules, thereby preventing unnecessary surgeries, according to the results of a study... Continue Reading

Low-Dose Radioiodine Effective in Thyroid Cancer (May 10, 2012)

Low-dose radioiodine is as effective as high-dose in the treatment of thyroid cancer, according to the results of two separate studies published in the New England Journal of Medicine. The results mean... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing... Continue Reading

Cabozantinib Shows Benefit in Medullary Thyroid Cancer (October 28, 2011)

In a Phase III clinical trial, the investigational drug cabozantinib significantly delayed the progression of advanced medullary thyroid cancer. Detailed results are expected to be presented at an upcoming... Continue Reading

Use of Radioactive Iodine for Thyroid Cancer Has Increased (August 29, 2011)

Use of radioactive iodine for the treatment of well-differentiated thyroid cancer has increased over time in the United States, even among patients who have an excellent prognosis with surgery alone. These... Continue Reading

Stay on Top of Your Family History of Cancer (July 15, 2011)

People who are at high risk of cancer as a result of their family history may be advised to undergo earlier or more intensive cancer screening. Because family history of cancer can change over time, it’s... Continue Reading

Fosbretabulin Tromethamine in Addition to Chemotherapy may Improve Survival in Advanced Thyroid Cancer (June 9, 2011)

The addition of fosbretabulin tromethamine (CA4P) to standard chemotherapy significantly improved survival at one year compared to chemotherapy alone in advanced anaplastic thyroid cancer. These results... Continue Reading

Vandetanib Approved for Medullary Thyroid Cancer (April 12, 2011)

The US Food and Drug Administration (FDA) has approved vandetanib for the treatment of adult patients with metastatic, medullary thyroid cancer that is growing or causing symptoms and cannot be treated... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS